Minerva Neurosciences (NERV) Prepaid Assets (2013 - 2026)
Minerva Neurosciences posted quarterly Prepaid Assets of $941883.0 for Q1 2026, up 76.12% year-on-year from $534798.0 in Q1 2025, and up 35.0% on a QoQ basis from $697676.0 in Q4 2025.
Minerva Neurosciences (NERV) has 14 years of Prepaid Assets data on file, last reported at $941883.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 76.12% year-over-year to $941883.0; the trailing twelve-month figure through Mar 2026 stood at $941883.0 (up 76.12% YoY), and the FY2025 full-year result was $697676.0, down 13.54% from the prior year.
- Prepaid Assets for Q1 2026 stood at $941883.0, up from $697676.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.4 million in Q3 2022 and bottomed at $184821.0 in Q2 2022.
- The 5-year median for Prepaid Assets is $697676.0 (2025), against an average of $733855.5.
- The widest annual swing landed in 2022, when Prepaid Assets tumbled 79.7%; it then jumped 78.09% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $848117.0 in 2022, then rose by 16.71% to $989865.0 in 2023, then declined by 18.48% to $806895.0 in 2024, then decreased by 13.54% to $697676.0 in 2025, then surged by 35.0% to $941883.0 in 2026.
- The last three Prepaid Assets figures came in at $941883.0 (Q1 2026), $697676.0 (Q4 2025), and $633533.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Minerva Neurosciences | 215.11 Mn | 215.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 941,883.00 |
| Dec 31, 2025 | 697,676.00 |
| Sep 30, 2025 | 633,533.00 |
| Jun 30, 2025 | 199,615.00 |
| Mar 31, 2025 | 534,798.00 |
| Dec 31, 2024 | 806,895.00 |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 428,018.00 |
| Mar 31, 2024 | 702,546.00 |
| Dec 31, 2023 | 989,865.00 |
| Sep 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 329,153.00 |
| Mar 31, 2023 | 596,045.00 |
| Dec 31, 2022 | 848,117.00 |
| Sep 30, 2022 | 1.40 Mn |
| Jun 30, 2022 | 184,821.00 |
| Mar 31, 2022 | 650,481.00 |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.75 Mn |
| Jun 30, 2021 | 910,577.00 |
| Mar 31, 2021 | 1.45 Mn |
| Dec 31, 2020 | 1.98 Mn |
| Sep 30, 2020 | 2.37 Mn |
| Jun 30, 2020 | 542,746.00 |
| Mar 31, 2020 | 851,864.00 |
| Dec 31, 2019 | 1.18 Mn |
| Sep 30, 2019 | 1.38 Mn |
| Jun 30, 2019 | 1.45 Mn |
| Mar 31, 2019 | 1.05 Mn |
| Dec 31, 2018 | 1.92 Mn |
| Sep 30, 2018 | 3.70 Mn |
| Jun 30, 2018 | 3.23 Mn |
| Mar 31, 2018 | 4.24 Mn |
| Dec 31, 2017 | 1.30 Mn |
| Sep 30, 2017 | 1.07 Mn |
| Jun 30, 2017 | 421,693.00 |
| Mar 31, 2017 | 791,513.00 |
| Dec 31, 2016 | 803,241.00 |
| Sep 30, 2016 | 702,359.00 |
| Jun 30, 2016 | 278,157.00 |
| Mar 31, 2016 | 617,780.00 |
| Dec 31, 2015 | 1.20 Mn |
| Sep 30, 2015 | 1.24 Mn |
| Jun 30, 2015 | 308,976.00 |
| Mar 31, 2015 | 503,317.00 |
| Dec 31, 2014 | 756,979.00 |
| Sep 30, 2014 | 583,539.00 |
| Jun 30, 2014 | 33,213.00 |
| Dec 31, 2013 | 852.00 |